Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-11

Clinical Trial Update: n-3 Polyunsaturated Fatty Acids to Prevent and Treat Diabetic Neuropathy [NA]

View source ↗

Summary

A clinical trial evaluating n-3 polyunsaturated fatty acids for prevention and treatment of diabetic neuropathy has been terminated. No additional results are a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: University of Missouri-Columbia | Conditions: Diabetic Neuropathies | NA | Status: TERMINATED